Joke Van Den Berg - Concepedia

Author

Joke Van Den Berg

Janssen (Belgium)

Also Known As

J Berg, Joke Van Den Berg, Joke Van den Berg

Publications

328

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Janssen (United States)Dartmouth College

About

Joke Van Den Berg is an author at Janssen (Belgium) specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	126
2	Health Sciences	1	1	39
3	Natural Sciences	1	1	26
4	Allergy	1	1	26
5	Biochemistry	1	1	26

Joke Van Den Berg

Publications

320

Citations

H-Index

Page 1

	Year	Citations
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor Dirk Roymans, Sarhad Alnajjar, Michael B. Battles, Nature Communications	2017	90
Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model Nacer Lounis, Tom Gevers, Joke Van Den Berg, Antimicrobial Agents and Chemotherapy Tuberculosis TreatmentTuberculosis PreventionImmunologyPharmacotherapyAntimicrobial Chemotherapy	2008	61
ATP Synthase Inhibition of <i>Mycobacterium avium</i> Is Not Bactericidal Nacer Lounis, Tom Gevers, Joke Van Den Berg, Antimicrobial Agents and Chemotherapy	2009	50
Prevention of Drug Carryover Effects in Studies Assessing Antimycobacterial Efficacy of TMC207 Nacer Lounis, Tom Gevers, Joke Van Den Berg, Journal of Clinical Microbiology Drug Carryover EffectsImmunologyDifferent MediaAntimicrobial ChemotherapyCulture Medium	2008	39
Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region David C. McGowan, Wendy Balemans, Werner Embrechts, Journal of Medicinal Chemistry	2019	26
Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1<i>H</i>-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus Sandrine Vendeville, Abdellah Tahri, Lili Hu, Journal of Medicinal Chemistry Respiratory Virus ImmunityAntiviral DrugChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2020	26
Evaluation of Antiviral Efficacy Against Human Respiratory Syncytial Virus Using Cotton Rat and Mouse Models Joke Van Den Berg, Leen Kwanten, Dirk Roymans Methods in molecular biology	2013	18
Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus Infections Bart Kesteleyn, Florence Herschke, Nicolas Darville, Journal of Medicinal Chemistry	2024	10

Page 1